Videos

Senate Finance Committee Chair Chuck Grassley (R-IA), Senate Finance Subcommittee on Health Care Ranking Member Deb Statenow (D-MI), former FDA Commissioner Scott Gottlieb, and others…

Dr. Scott Gottlieb spoke at a National Press Club luncheon The former Food and Drug Administration commissioner discussed the future of the agency and why he decided to leave. He also…

Dr. Scott Gottlieb, the outgoing Food and Drug Administration commissioner, about his tenure and the future of the agency. Among the issues discussed were tobacco and nicotine regulation,…

Food and Drug Administration (FDA) CommissionerScott Gottlieb talked about his agency’s efforts in combating the opioid epidemic at an event hosted by Politico. The event also included a…

Scott Gottlieb talked about the nation’s opioid epidemic, as well as drug prices and the Food and Drug Administration’s efforts to cut nicotine levels in cigarettes.

The House Energy and Commerce Subcommittee on Health convened a hearing to examine the nation’s opioid epidemic and ways to combat it. The two-day hearing began with witnesses from the federal…

FDA Commissioner Scott Gottlieb delivered the keynote remarks at a National Press Club Headliners Luncheon. He talked about the Food and Drug Administration’s efforts to evaluate and approve new…

Members of Congress and industry experts talked about prescription drug access and costs. FDA Commissioner Scott Gottlieb also participated in the event and talked about the FDA’s role in…

Commissioner Scott Gottlieb testified before a Senate Appropriations subcommittee on the President Trump’s fiscal year 2018 Food and Drug Administration budget request. The budget proposes cutting…

Dr. Scott Gottlieb testified at a confirmation hearing on his nomination to be commissioner of the Food and Drug Administration (FDA). He said his priorities at the FDA would be combating opioid…

Scott Gottlieb talked about the methods used by pharmaceutical companies when determining drug prices, as well as the Food and Drug Administration’s role in the drug market.

Deputy Commissioner Gottlieb talked about a new Food and Drug Administration rule, which takes effect June 30, that mandates that drug labels become easier to read. The rule requires labels…

The Senate Health, Education, Labor and Pensions Committee heard testimony from medical experts and consumer advocates on drug safety and the approval process for new drugs. Among the…